West Pharmaceutical Services, Inc. (WST) Profit Margin
West Pharmaceutical Services, Inc. (WST) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 9.52% |
| 2017-12-31 | 9.42% |
| 2018-12-31 | 12.05% |
| 2019-12-31 | 13.14% |
| 2020-12-31 | 16.13% |
| 2021-12-31 | 23.37% |
| 2022-12-31 | 20.30% |
| 2023-12-31 | 20.12% |
| 2024-12-31 | 17.03% |
| 2025-12-31 | 16.06% |
How WST compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| EW | Edwards Lifesciences Corporation | 17.69% |
| NBIX | Neurocrine Biosciences Inc. | 16.73% |
| TMO | Thermo Fisher Scientific Inc | 15.05% |
| DHR | Danaher Corporation | 14.71% |
| BSX | Boston Scientific Corporation | 14.44% |
These are five companies in the same sector as WST with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get West Pharmaceutical Services, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("WST", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | WST | $362.31 | -1.17% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 |